Impel
Impel is a Washington-based biopharmaceutical company that develops and commercializes nasal drug delivery therapeutics for the treatment of CNS disorders.
Business Model:
Revenue: $8.2M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Impel Information
Geographic Data
Address: 201 Elliott Avenue West
City: Seattle
State: WA
Zip: 98119
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$50M
Raised Total:$261M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Impel is a Washington-based biopharmaceutical company that develops and commercializes nasal drug delivery therapeutics for the treatment of CNS disorders.
Contact Phone:
+12065681466
Contact Email:
Impel went public on 4/22/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/22/2021
IPO Valuation:
$291M
Ticker Symbol:
IMPL
IPO Price:
$15/share
Amount Raised:
$80M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
